Results 31 to 40 of about 5,421 (159)

Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy

Frontiers in Medicine
Meningitis caused by Acinetobacter species is a rare complication of neurosurgical procedures, although it is associated with high morbidity and mortality.
Nicholas Mercuro
exaly   +3 more sources

Successful Treatment of OXA-23 <i>Acinetobacter baumannii</i> Pneumonia with Sulbactam-Durlobactam in a Liver Transplant Recipient. [PDF]

Infect Drug Resist
Liver transplant recipients face a higher risk of multidrug-resistant (MDR) infections because of preoperative comorbidities, extensive antibiotic use, immunosuppressive therapy, and prolonged mechanical ventilation. Carbapenem-resistant Acinetobacter baumannii (CRAB) remains one of the most challenging pathogens in this group.
Yin G, Liu Z, Fu Z, Zhong Z, Ye S, Pan H.   +5 more
europepmc   +3 more sources

Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam. [PDF]

Clin Infect Dis
Abstract Background The treatment of carbapenem-resistant Acinetobacter baumannii/calcoaceticus complex (CRAB) presents significant treatment challenges. Methods We report the case of a 42-year-old woman with CRAB meningitis who ...
Tamma PD, Immel S, Karaba SM, Soto CL, Conzemius R, Gisriel E, Tekle T, Stambaugh H, Johnson E, Tornheim JA, Simner PJ.   +10 more
europepmc   +3 more sources

Management of extensively drug-resistant <i>Acinetobacter baumannii</i> bacteremia with cefiderocol and sulbactam-durlobactam: a case report. [PDF]

ASM Case Rep
ABSTRACT Background Extensively drug-resistant (XDR) Acinetobacter baumannii presents an urgent threat to public health due to its significant morbidity and mortality, with ...
Kim EJ, Snyder M, Macaluso K, Sonyey A, Segovia F, Finkel D, Cennimo D, Kim EL.   +7 more
europepmc   +3 more sources

Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests

Journal of Clinical Microbiology
ABSTRACT Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination developed to treat hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex (ABC).
Patricia Bradford, Nicole Carter, Alita Miller   +2 more
exaly   +3 more sources

The epidemiological and molecular characteristics and sulbactam-durlobactam susceptibility of carbapenem-resistant Acinetobacter baumannii in a Chinese teaching hospital

Journal of Global Antimicrobial Resistance
: Objectives: This study aimed to investigate sulbactam-durlobactam (SUL-DUR) susceptibility and molecular features of carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from a Shenzhen teaching hospital. Methods: A retrospective study on CRAB
Hanlian Huang, Qiaomin Zhang, Shaobo Li, Xiaoyan Dai, Zhongbiao Chen, Guili Zhang, Wen Ma, Hongwei Shen   +7 more
doaj   +3 more sources

Turning the Tide Against Carbapenem-resistant <i>Acinetobacter baumannii</i>: Advancing Care With Sulbactam-Durlobactam. [PDF]

Open Forum Infect Dis
Satlin M, Shields RK, Torres A, Tillotson G.   +3 more
europepmc   +3 more sources

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates ofAcinetobacter baumannii

Antimicrobial Agents and Chemotherapy, 2023
ABSTRACTAcinetobacter baumannii-calcoaceticuscomplex (ABC) causes severe infections that are difficult to treat due to pre-existing antibiotic resistance. Sulbactam-durlobactam (SUL-DUR) is a targeted β-lactam/β-lactamase inhibitor combination antibiotic designed to treat serious infections caused byAcinetobacter, including multidrug- and carbapenem ...
Samir H. Moussa, Adam B. Shapiro, Sarah M. McLeod, Ramkumar Iyer, Nicole M. Carter, Yu-Kuo Tsai, L. Kristopher Siu, Alita A. Miller   +7 more
openaire   +2 more sources

Sulbactam-durlobactam in combination with aztreonam and carbapenems against carbapenem-resistant Acinetobacter baumannii: an assessment using the MIC-based broth disk elution [PDF]

Journal of Clinical Microbiology
C. Koenig, D. P. Nicolau, T.E. Asempa
doaj   +2 more sources

Carbapenem‐Resistant Acinetobacter baumannii Bloodstream Infection in a Ghanaian Patient with Unilateral Diaphragmatic Eventration and HIV Type 1 Infection

Case Reports in Infectious Diseases, Volume 2023, Issue 1, 2023., 2023
Carbapenem‐resistant Acinetobacter baumannii infection is a critically prioritized pathogen by the World Health Organization and a cause for growing concern due to increased mortality among hospitalised patients. Phrenic nerve palsy is a rare complication of herpes zoster infection of the C3, C4, and C5 nerve roots.
Yvonne Ayerki Nartey, Augustine Boakye Donkor, Ampem Darko Jnr Siaw, Oluwayemisi Esther Ekor, Bashiru Babatunde Jimah, Dawei Cui   +5 more
wiley   +1 more source